HCWB HCW Biologics Inc
Company Analysis
Latest News
🔴 HCW Biologics Inc is trading 12.3% down today on broad risk-off pressure in small-cap biotech
HCW Biologics Inc is trading 12.3% down at $1.43 in after-hours trading as macroeconomic headwinds continue to weigh on the small-cap biotech sector. • The...
🔴 HCW Biologics Inc is trading 7.4% down today amid broad risk-off sentiment following strong U.S. jobs data
HCW Biologics Inc is trading 7.4% down at $1.51 as small-cap biotech shares face pressure from a broader market sell-off in growth names. • The move appears...
🔴 HCW Biologics Inc is trading 11.2% down today on Nasdaq compliance and dilution worries
HCW Biologics Inc is trading 11.2% down at $1.59 today as investors react to Nasdaq minimum bid-price compliance worries and potential dilution from a recently...
🔴 HCW Biologics Inc is trading 6.7% down today on Nasdaq compliance worries and dilution fears
HCW Biologics Inc is trading 6.7% down at $1.67 in pre-market, extending weakness following its Q1 update and ongoing Nasdaq minimum bid-price compliance...
🔴 HCW Biologics Inc is trading 11.6% down today amid Q1 2026 update and Nasdaq compliance concerns
HCW Biologics Inc is trading at $1.83 (11.6% down) following its recent first-quarter 2026 update and shifts in its capital structure. • The company is under...
🔴 HCW Biologics Inc is trading 12.09% down
HCWB is trading at $1.82, down 12.09%.
🔴 HCW Biologics Inc is trading 8% down today on dilution risk from warrant repricing
HCW Biologics Inc is trading 8% down today at $1.91 as investors react to dilution risks stemming from a warrant repricing and ongoing concerns regarding its...
HCW Biologics Dodges Delisting for Now, but Can a $2 Stock With No Revenue Buy Enough Time?
Shares of HCW Biologics (HCWB) ticked up 3.5% to $2.05 after the company disclosed that a Nasdaq Hearings Panel granted it additional time to regain compliance...
🟢 HCW Biologics Inc is trading 3.5% up today as Nasdaq extension eases delisting concerns
HCW Biologics Inc is trading 3.5% up today at $2.05 after disclosing that Nasdaq granted the company an extension to regain minimum bid-price compliance,...
🔴 HCWB is trading 5.26% down in after-hours
HCWB is trading at $1.98, down 5.26% in after-hours.
🟢 HCWB is trading 4.31% up in pre-market
HCWB is trading at $2.18, up 4.31% in pre-market.
🟢 HCWB is trading 6.2% up today as it rebounds after regaining rights to key molecules
HCWB is trading 6.2% up today at $2.06 as it rebounds from a sharp selloff on May 27, 2026, following the termination of its licensing agreement with Wugen. •...
🔴 HCWB is trading 22.7% down today after terminating its Wugen license agreement to regain rights to key molecules
HCWB is trading 22.7% down today at $2.02 after the company announced it has terminated an exclusive worldwide license agreement with Wugen to regain full ex...
🔴 HCWB is trading 9.9% down today after terminating its Wugen license deal to regain molecule rights
HCWB is trading approximately 9.9% down at $2.36 after announcing the termination of its exclusive worldwide license agreement with Wugen. • By ending the...
HCW Biologics Terminates Wugen Agreement, Regains Full Rights to Two Immunotherapeutics
HCW Biologics Inc. announced it has terminated its exclusive worldwide license agreement with Wugen Inc., regaining full ex vivo rights to its...
🔴 HCWB is trading 12.1% down today on profit-taking after a massive multi-session rally
HCWB is trading 12.1% down today at $2.54 as the stock enters a consolidation phase following a dramatic surge from $0.34 to the mid-$2 range. • The recent...
🟢 HCWB is trading 5% up today, extending recent rally driven by Q1 results and financing
HCWB is trading 5% up at $2.72 in pre-market, continuing a major rally that began in mid-May. • The surge appears driven by strong Q1 2026 financial results...
🟢 HCWB is trading 27% up today after $4M private placement and preclinical data
HCWB is trading at $3.26 (+26.53%) today after announcing a $4.0 million private placement and releasing positive preclinical data for its T-cell engager...
🟢 HCWB is trading 55% up today after a $4M private placement and promising preclinical data
HCWB is trading 55% up at $4.01 in pre-market trading, extending a significant two-day rally following key corporate updates. • The company secured a $4.0...
HCW Biologics Announces ~$4.0 Million Private Placement with Accredited Investors
HCW Biologics Inc. entered into a Securities Purchase Agreement with accredited investors to raise approximately $4.0 million in gross proceeds. The private...